Free Trial

Legend Biotech (LEGN) Earnings Date, Estimates & Call Transcripts

Legend Biotech logo
$38.19 -1.70 (-4.26%)
(As of 11/15/2024 ET)

Legend Biotech Latest Earnings Summary

Upcoming Q4
Earnings Date
Mar. 10Estimated
Actual EPS
(Nov. 12)
-$0.34 Beat By $0.22
Consensus EPS
(Nov. 12)
-$0.56

Legend Biotech released Q3 2024 earnings on November 12, 2024, reporting an EPS of -$0.34, which beat the consensus estimate of -$0.56 by $0.22. Quarterly revenue rose 66.9% year-over-year to $160.20 million, above analysts' expectations of $143.91 million. With a trailing EPS of -$0.95, Legend Biotech's earnings are expected to grow next year, from ($1.23) to ($0.41) per share.

LEGN Upcoming Earnings

Legend Biotech's next earnings date is estimated for Monday, March 10, 2025, based off prior year's reporting schedules.

Get Legend Biotech Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Legend Biotech and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

LEGN Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

LEGN Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Legend Biotech Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20242-$0.62-$0.01-$0.32
Q2 20242-$0.51-$0.34-$0.43
Q3 20242-$0.44-$0.34-$0.39
Q4 20242-$0.32-$0.31-$0.32
FY 20248-$1.89-$1.00-$1.45
Q1 20252-$0.30-$0.19-$0.25
Q2 20252-$0.20$0.24$0.02
Q3 20252-$0.18-$0.14-$0.16
Q4 20252-$0.05$0.12$0.04
FY 20258($0.73)$0.03($0.35)

Legend Biotech Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks
3/10/2025
(Estimated)
------- 
11/12/2024Q3 2024-$0.56-$0.34+$0.22-$0.34$143.91M$160.20M    
8/9/2024Q2 2024-$0.54-$0.05+$0.49-$0.05$125.25M$186.50M    
5/13/2024Q1 2024-$0.29-$0.16+$0.13-$0.16$143.24M$93.90M      
3/11/2024Q4 2023-$0.70-$0.40+$0.30-$0.40$95.63M$76.50M      
11/20/2023Q3 2023-$0.31-$0.17+$0.14-$0.17$97.25M$96.00M      
8/15/2023Q2 2023-$0.36-$0.57 -$0.21$0.03$56.64M$73.30M  
5/18/2023Q1 2023-$0.56-$0.40+$0.16-$0.46$37.06M$36.34M
2/17/2023Q2 2022--$0.41 -$0.41-$0.20-$11.97M

Legend Biotech Earnings - Frequently Asked Questions

Legend Biotech has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 10th, 2025 based off last year's report dates. Learn more on LEGN's earnings history.

In the previous quarter, Legend Biotech (NASDAQ:LEGN) reported ($0.34) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.56) by $0.22. Learn more on analysts' earnings estimate vs. LEGN's actual earnings.

The conference call for Legend Biotech's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Legend Biotech's latest earnings report can be read online.
Read Transcript

Legend Biotech (NASDAQ:LEGN) has a recorded annual revenue of $285.14 million.

Legend Biotech (NASDAQ:LEGN) has a recorded net income of -$518.25 million. LEGN has generated -$0.95 earnings per share over the last four quarters.

Legend Biotech's earnings are expected to grow from ($1.23) per share to ($0.41) per share in the next year.

`

More Earnings Resources from MarketBeat



This page (NASDAQ:LEGN) was last updated on 11/17/2024 by MarketBeat.com Staff
From Our Partners